Skip to Main content Skip to Navigation
Journal articles

Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.

Abstract : The Tn antigen (GalNAcα-O-Ser/Thr) is a well-established tumor-associated marker which represents a good target for the design of anti-tumor vaccines. Several studies have established that the binding of some anti-Tn antibodies could be affected by the density of Tn determinant or/and by the amino acid residues neighboring O-glycosylation sites. In the present study, using synthetic Tn-based vaccines, we have generated a panel of anti-Tn monoclonal antibodies. Analysis of their binding to various synthetic glycopeptides, modifying the amino acid carrier of the GalNAc(*) (Ser* vs Thr*), showed subtle differences in their fine specificities. We found that the recognition of these glycopeptides by some of these MAbs was strongly affected by the Tn backbone, such as a S*S*S* specific MAb (15G9) which failed to recognize a S*T*T* or a T*T*T* structure. Different binding patterns of these antibodies were also observed in FACS and Western blot analysis using three human cancer cell lines (MCF-7, LS174T and Jurkat). Importantly, an immunohistochemical analysis of human tumors (72 breast cancer and 44 colon cancer) showed the existence of different recognition profiles among the five antibodies evaluated, demonstrating that the aglyconic part of the Tn structure (Ser vs Thr) plays a key role in the anti-Tn specificity for breast and colon cancer detection. This new structural feature of the Tn antigen could be of important clinical value, notably due to the increasing interest of this antigen in anticancer vaccine design as well as for the development of anti-Tn antibodies for in vivo diagnostic and therapeutic strategies.
Document type :
Journal articles
Complete list of metadatas

Cited literature [59 references]  Display  Hide  Download

https://hal-riip.archives-ouvertes.fr/pasteur-00847180
Contributor : Mariella Botta <>
Submitted on : Monday, July 22, 2013 - 9:17:22 PM
Last modification on : Friday, October 16, 2020 - 11:20:04 AM
Long-term archiving on: : Wednesday, April 5, 2017 - 4:10:37 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Daniel Mazal, Richard Lo-Man, Sylvie Bay, Otto Pritsch, Edith Dériaud, et al.. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer.. Cancer Immunology, Immunotherapy, Springer Verlag, 2013, 62 (6), pp.1107-22. ⟨10.1007/s00262-013-1425-7⟩. ⟨pasteur-00847180⟩

Share

Metrics

Record views

351